Header
Look deeper into the management of dedifferentiated liposarcoma (DDLPS).

Looking deeper into the management of dedifferentiated liposarcoma (DDLPS)

A multidisciplinary management approach is recommended for improved patient outcomes in DDLPS1

  • The complexity of the disease emphasises the necessity of a multidisciplinary approach involving a specialised team of sarcoma experts to manage these patients2

It takes a team to take on DDLPS2,3

It takes a team to take on DDLPS

  • Treatment at specialised centres provides better outcomes in patients with DDLPS4

Integrated Cancer Program DDLPS Life Expectancy

*Results from a retrospective study of 3573 patients with DDLPS.4

†An entity that offers integrated and comprehensive cancer care services.5

Patients diagnosed with advanced DDLPS have had no new first-line treatment options in nearly 50 years6,7 

Uncover the possibilities for your patients

Expand Your Knowledge

Sarcoma Alliance: sarcomaalliance.org/

Sarcoma Alliance for Research through Collaboration (SARC): sarctrials.org/

Sarcoma Patients Advocacy Global Network (SPAGN): sarcoma-patients.org/

References:

  1. Danieli M, Swallow CJ, Gronchi A. Eur J Surg Oncol. 2023;49(6):1068-1080.

  2. Gamboa AC, Gronchi A, Cardona K. CA Cancer J Clin. 2020;70(3):200-229.

  3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Soft Tissue Sarcoma V.3.2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed 6 March 2024. To view the most recent and complete version of the guidelines, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

  4. Gootee JM, Curtin CE, Aurit SJ, Randhawa SE, Kang BY, Silberstein PT. Federal Pract. 2019;36(Suppl 5):S34-S41.

  5. ACS CoC. Accreditation Guidelines for an Integrated Network Cancer Program (INCP) or National Cancer Institute-Designated Network Cancer Program (NCIN). Accessed 6 March 2024. 
https://accreditation.facs.org/AccreditationDocuments/Coc/resources/CoC_INCP_NCIN_Guidelines.pdf

  6. McGovern Y, Zhou CD, Jones RL. Front Oncol. 2017;7:292. doi:10.3389/fonc.2017.00292

  7. Italiano A. Cancer Discov. 2023;13(8):1765-1767.